πŸ“… 2026 Update: Recent Developments in Drug and Medical Device Lawsuits

Since the original article was published, there have been significant changes in lawsuits related to drugs and medical devices. Key cases have emerged, reflecting ongoing concerns about product safety and liability. The earlier article continues below, providing a comprehensive overview of the legal landscape.

🚨 Ozempic Lawsuit Growth

As of June 2026, there are 3,763 lawsuits against Ozempic and similar drugs. These cases allege severe gastrointestinal injuries and vision loss. All these lawsuits are now consolidated in federal court in Pennsylvania.

This consolidation aims to streamline the legal process for those affected.

βš–οΈ Depo-Provera Litigation Expansion

The Depo-Provera case has seen a notable increase. By June 2026, the litigation had grown to over 5,500 cases alleging a connection between the contraceptive and brain tumors. This rise marks significant legal activity and concern regarding the safety of the drug.

πŸ’° Gardasil Settlement News

In June 2026, Merck agreed to a $50 million settlement for over 200 Gardasil-related cases. This settlement includes cases that had been previously dismissed. It highlights the ongoing issues surrounding vaccine safety and liability claims in the medical field.

πŸ“… Upcoming Trials in Ozempic MDL

As of June 2026, no trials have occurred in the Ozempic multidistrict litigation. Bellwether trials are expected to start in late 2026 or early 2027. These initial trials will be crucial in determining how similar cases may proceed.

πŸ“Œ Key Takeaways

  • 🚨 Ozempic lawsuits consolidated with 3,763 claims.
  • βš–οΈ Depo-Provera litigation expanded to over 5,500 cases.
  • πŸ’° Merck's $50 million settlement for Gardasil claims.
  • πŸ“… Ozempic trials expected to begin late 2026 or early 2027.
  • βš–οΈ Ongoing concerns about drug safety and liability persist.

πŸ’‘ Tips for Understanding Product Liability Lawsuits

Reviewing your situation with your attorney is essential for understanding your options.

πŸ“œ Understand Eligibility for Ozempic Claims

Individuals who have developed severe gastrointestinal injuries or vision loss after using Ozempic may be eligible for lawsuits. This could provide a pathway for compensation if you meet the criteria.

πŸ“Š Monitor Depo-Provera Developments

Stay updated on the Depo-Provera cases. More than 5,500 lawsuits indicate serious concerns. If you’ve been diagnosed with brain tumors after using this contraceptive, you might have grounds for a claim.

πŸ“… Note Deadlines for Filing Claims

The first Depo-Provera lawsuit was filed on October 1, 2024. Keep in mind the applicable statutes of limitations for filing your claim. Missing these deadlines can affect your ability to seek compensation.

🀝 Explore Free Legal Assistance

Consider reaching out to nonprofit organizations that may offer free legal help. They can assist individuals pursuing claims related to product liability, especially for those who cannot afford legal representation.

πŸ“£ Stay Informed on Settlements

Keep an eye on settlements like the one from Merck regarding Gardasil. Knowing about these settlements can help you gauge the potential outcomes of similar lawsuits.

πŸ† Free Options Ranked by User Reviews (2026)

No paid services met the review threshold for this topic. Instead, this section lists free government and nonprofit resources available for those pursuing product liability claims.

πŸ₯‡ 1. FDA's Role

The FDA provides essential information on drug safety and adverse events. Individuals seeking information about pharmaceutical injuries can find resources that clarify the risks associated with various medications.

πŸ₯ˆ 2. Legal Aid Organizations

Nonprofit organizations offer free legal assistance to individuals pursuing product liability claims. These organizations can help individuals navigate the complexities of legal processes without incurring costs.

πŸ₯‰ 3. Community Health Resources

Local community health organizations may provide information on medical issues related to drugs and devices. They often have resources that can guide individuals in understanding their health concerns and legal options.

4️⃣ State Health Departments

State health departments can provide information about drug recalls and safety alerts. They help individuals stay informed about potential risks related to medications and medical devices.

5️⃣ Advocacy Groups

Various advocacy groups focus on patient safety and product liability issues. These groups can offer support and resources for individuals affected by harmful medications or devices.

πŸ”Ž What to Check Before Paying for Help

  • πŸ” Verify credentials and reviews of any service.
  • πŸ“… Confirm the service's experience with drug-related cases.
  • πŸ’Ό Ask about potential costs and fees upfront.
  • πŸ›‘οΈ Ensure they offer clear communication and updates.

❓ Frequently Asked Questions

❓ What types of injuries are linked to Ozempic?

Ozempic has been associated with severe gastrointestinal injuries and vision loss. These claims are central to the ongoing lawsuits against the drug.

⚠️ How can I file a lawsuit for Depo-Provera?

To file a lawsuit for Depo-Provera, you need to demonstrate a diagnosis of brain tumors after using the contraceptive. Legal assistance can guide you through the filing process.

πŸ“… Are there deadlines for filing lawsuits related to Gardasil?

Yes, there are deadlines for filing lawsuits regarding Gardasil. It's important to be aware of the applicable statutes of limitations.

πŸ“ˆ What is the status of ongoing trials for Ozempic?

As of June 2026, no trials have occurred in the Ozempic multidistrict litigation. Trials may begin in late 2026 or early 2027, which will be significant for claimants.

πŸ₯ Where can I find more information about drug safety?

The FDA provides information on drug safety and adverse events. This resource can help individuals understand the risks associated with medications.

πŸ’Ό What should I consider before pursuing a lawsuit?

Consider the eligibility criteria, potential costs, and the legal process involved. Understanding these factors can help you make informed decisions about pursuing a claim.

βš–οΈ Recent Cases Connected to Drug Liability

Recent court rulings reflect ongoing issues related to product liability, particularly concerning drugs and medical devices. These cases highlight the legal challenges faced by individuals affected by harmful products.

For more recent rulings, check out more rulings on the news page.

End of October 2026 Update






Evista Lawsuits: What is Evista?





Evista is an oral hormone drug used to combat osteoporosis in post-menopausal women. Produced by the Eli Lilly and Company, Evista uses Raloxifene to mimic the effects of estrogen. In addition to the aforementioned use, Evista is also effective in decreasing the risk of invasive breast cancer.





Evista belongs to a class of medications known as selective estrogen receptor modulators. The drug is effective, in preventing osteoporosis, by mimicking estrogen to increase bone density; to prevent the development of breast cancer, Evista blocks the effects of estrogen on breast tissue.





Evista Side Effects:





Evista side effects may present themselves even with proper administration. Please contact your doctor, if your Evista side effects are particularly bothersome or persistent:



• Evista side effects include Leg Cramps



• Hot Flashes (common in the first 6 months of Evista application)



• Evista side effects include Swelling of the feet, hands, lower legs or ankles



• Flu-like symptoms are common Evista side effects



•Evista side effects include joint pain



•Sweating is a common Evista side effect.



• Evista side effects include Difficulty falling or staying asleep





Other Evista side effects may be more serious. If you experience any of the symptoms mentioned on the drug’s warning label, please call your medical provider or doctor immediately. If you experience severe side effects, you or your medical professional should send a report to the United States Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting program by phone at (1-800-332-1088) or online at https://www.fda.gov/Safety/MedWatch.





Evista Lawsuits:



Evista lawsuits primarily stem from off-label use of the drug. In October of 2002, the Cancer Prevention Coalition issued a statement stating that women taking Evista face an increased risk of developing ovarian cancer. “There is ample scientific evidence that Evista poses risks of ovarian cancer,” said Samuel Epstein, MD Chairman of the Prevention Coalition.





Additionally, a study conducted by the University of Southern California, provided further evidence of the drug’s cancer risk. The study, which is used as a basis for Evista lawsuits, shows the drug to increase the growth rate of ovarian cancer cells and may increase the risk of recurrent ovarian cancer.





In light of this information, an Evista lawsuit was filed by the United States Department of Justice; this particular Evista lawsuit was initiated in light of an increasing number of women developing ovarian cancer from Evista. This Evista lawsuit required the Eli Lilly Company to pay the USDJ $36 million.





In addition to this Evista settlement, other Evista lawsuits have been filed because of the drug’s link to strokes. In May of 2006, the Eli Drug Company issued new safety warnings concerning an increased risk of death due to stroke for patients who are susceptible to cardiovascular diseases. These Evista side effects were discovered during the RUTH (Raloxifene Use for the Heart) trial. The study found—as a basis for Evista lawsuits—an increase in death from stroke for Evista compared to a placebo. The rate of stroke mortality was 1.5 per 1,000 users per year for the placebo and 2.2 per 1,000 users per year for Evista.





These studies form a basis for Evista lawsuits, because the Eli Lilly Company did not properly warn users of said risks. Ultimately, this information led to a swarm of Evista lawsuits and subsequent Evista settlements for patients who developed severe Evista side effects.





To date, even with the underreporting concerning the severity of Evista side effects, there have been only a handful of Evista lawsuits decided against Eli Lilly. Moreover, no Evista lawsuits have yielded significant rewards in class action Evista lawsuits. Although a dearth of legal action has been taken against Evista, all users should consider the Evista side effects, and if appropriate, consult with their doctor to determine if there are any foreseeable dangers in connection with use.





Every state in the U.S. institutes new laws against negligence by health care providers, employers, property owners and manufacturers. Under these personal injury statutes, if a user is injured by Evista, they have the right to file an Evista lawsuit to secure compensation to offset the costs associated with medical expenses and pain and suffering. If you feel that you have been victimized by Evista side effects, you must contact a product liability lawyer or a personal injury specialist to file an Evista lawsuit. If the legal specialist can affirm liability and link your damages to Evista side effects, the ability to secure an Evista settlement will be strong.





Sources:



1. Raloxirfene U.S. National Library of Medicine. Retrieved from



https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001022



2.“Evista Approved for Reducing Breast Cancer Risk” retrieved from:



https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048474.htm



3. https://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf